An experimental drug initially developed to fight cancer cut the risk of death for people hospitalized with Covid by half, according to a study published on Wednesday.
In early January, more than 700 Stanford University athletes took rapid Covid tests upon returning to the campus. Those who tested negative — and some who tested positive — were also given PCR tests.
Recent Comments